Paradigms for Precision Medicine in Epichaperome Cancer Therapy

Area of Science:

• Oncology
• Molecular Biology
• Biophysics

Background:

• Protein-protein interactions are crucial in cancer development.
• Current diagnostic tools do not effectively target these aberrant networks.
• The epichaperome represents a critical pathologic protein-protein interaction network in malignancy.

Purpose of the Study:

• To develop and validate an imaging probe for visualizing and quantifying the epichaperome in real-time.
• To assess the potential of this probe as a theranostic platform for precision medicine.
• To demonstrate the utility of quantitative epichaperome evaluation for optimizing cancer treatment.

Main Methods:

• Utilized kinetic selectivity properties of a novel imaging probe.
• Assayed and imaged epichaperome networks in patient tumors at single-lesion resolution.
• Performed quantitative evaluation of epichaperome engagement by inhibitors in real-time.

Main Results:

• Successfully visualized and measured epichaperome networks in cancer patients.
• Demonstrated real-time, single-lesion resolution imaging of these networks.
• Showcased quantitative evaluation for optimizing drug dose and schedule selection.

Conclusions:

• The developed imaging probe serves as a theranostic platform for precision medicine.
• This approach enables targeted therapy by addressing aberrant protein networks.
• Provides preclinical and clinical evidence for real-time, individualized cancer treatment strategies.